Who bought the Ruitelli Group?

Shanghai fosun pharmaceutical co., ltd.

According to official website information of Shanghai Fosun Pharma, as of June 26, 2023, Shanghai Fosun Pharma announced that its holding subsidiary, Fosun Pharma Industry, had completed the acquisition of Chengdu Taylor Biomedical Technology Co., Ltd., which mainly engaged in the research and development and production of biopharmaceutical products such as monoclonal antibody drugs, recombinant protein drugs, antibody-coupled drugs and recombinant humanized monoclonal antibody drugs. 65438-0997, it was restructured into Shanghai Fosun Pharma Co., Ltd., introduced the advanced operating mechanism and management mode of Fosun Pharma Group, gave full play to the capital and brand advantages of listed companies, strengthened services, expanded operations, and the sales and profits of enterprises increased rapidly.